Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1983 Mar;46(3):255–260. doi: 10.1136/jnnp.46.3.255

Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?

F Niklasson, H Agren, R Hällgren
PMCID: PMC1027333  PMID: 6188805

Abstract

In the cerebrospinal fluid of 38 patients with major depressive disorders the purine metabolites hypoxanthine and xanthine were positively correlated to the monoamine metabolites HVA and 5HIAA (p less than 0.0001). Hypoxanthine was also positively linked to the noradrenaline metabolite MHPG (p less than 0.005). By the use of multiple regression analysis 70% of the variance in hypoxanthine and 51% of the variance in xanthine were explained by HVA and 5HIAA. The scored magnitude of memory disturbance during depression was positively correlated to hypoxanthine, xanthine, HVA, and 5HIAA, while the degree of somatic anxiety as well as worrying was or tended to be negatively correlated to the same biochemical markers. The conspicuous relationship observed between purine and monoamine metabolite concentrations in CSF during depressive illness might indicate a parallel purinergic and monoaminergic activation of the brain. The observation that certain isolated depressive symptoms appear to relate to hypoxanthine/xanthine in CSF is consistent with the hypothesis of a central role of purines in behaviour.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns. Psychiatry Res. 1980 Oct;3(2):211–223. doi: 10.1016/0165-1781(80)90038-4. [DOI] [PubMed] [Google Scholar]
  2. Andersen O., Johansson B. B., Svennerholm L. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis. Acta Neurol Scand. 1981 Apr;63(4):247–254. [PubMed] [Google Scholar]
  3. Asberg M., Träskman L., Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976 Oct;33(10):1193–1197. doi: 10.1001/archpsyc.1976.01770100055005. [DOI] [PubMed] [Google Scholar]
  4. Dascombe M. J., Milton A. S. The effects of cyclic adenosine 3',5'-monophosphate and other adenine nucleotides on body temperature. J Physiol. 1975 Aug;250(1):143–160. doi: 10.1113/jphysiol.1975.sp011046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Endicott J., Spitzer R. L. Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders. Am J Psychiatry. 1979 Jan;136(1):52–56. doi: 10.1176/ajp.136.1.52. [DOI] [PubMed] [Google Scholar]
  6. FELDBERG W., SHERWOOD S. L. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167. doi: 10.1113/jphysiol.1954.sp005040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harms H. H., Wardeh G., Mulder A. H. Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology. 1979 Jul;18(7):577–580. doi: 10.1016/0028-3908(79)90107-2. [DOI] [PubMed] [Google Scholar]
  8. Haulică I., Ababei L., Brănişteanu D., Topoliceanu F. Letter: Preliminary data on the possible hypnogenic role of adenosine. J Neurochem. 1973 Oct;21(4):1019–1020. doi: 10.1111/j.1471-4159.1973.tb07549.x. [DOI] [PubMed] [Google Scholar]
  9. Israël M., Gautron J., Lesbats B. Fractionnement de l'organe electrique de la torpille: localisation subcellulaire de l'acetylcholine. J Neurochem. 1970 Oct;17(10):1441–1450. doi: 10.1111/j.1471-4159.1970.tb00511.x. [DOI] [PubMed] [Google Scholar]
  10. Lagercrantz H., Stajärne L. Evidence that most noradrenaline is stored without ATP in sympathetic large dense core nerve vesicles. Nature. 1974 Jun 28;249(460):843–845. doi: 10.1038/249843a0. [DOI] [PubMed] [Google Scholar]
  11. Lewin E. Endogenously released adenine derivatives: a possible role in epileptogenesis. Trans Am Neurol Assoc. 1976;101:192–195. [PubMed] [Google Scholar]
  12. Michaelis M. L., Michaelis E. K., Myers S. L. Adenosine modulation of synaptosomal dopamine release. Life Sci. 1979 May 28;24(22):2083–2092. doi: 10.1016/0024-3205(79)90082-1. [DOI] [PubMed] [Google Scholar]
  13. Phillis J. W., Wu P. H. The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol. 1981;16(3-4):187–239. doi: 10.1016/0301-0082(81)90014-9. [DOI] [PubMed] [Google Scholar]
  14. Pull I., McIlwain H. Adenine derivatives as neurohumoral agents in the brain. The quantities liberated on excitation of superfused cerebral tissues. Biochem J. 1972 Dec;130(4):975–981. doi: 10.1042/bj1300975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Santos J. N., Hempstead K. W., Kopp L. E., Miech R. P. Nucleotide metabolism in rat brain. J Neurochem. 1968 May;15(5):367–376. doi: 10.1111/j.1471-4159.1968.tb11623.x. [DOI] [PubMed] [Google Scholar]
  16. Schubert P., Rose G., Lee K., Lynch G., Kreutzberg G. W. Axonal release and transfer of nucleoside derivates in the entorhinal-hippocampal system: an autoradiographic study. Brain Res. 1977 Oct 7;134(2):347–352. doi: 10.1016/0006-8993(77)91078-2. [DOI] [PubMed] [Google Scholar]
  17. Sulakhe P. V., Phillis J. W. The release of 3H-adenosine and its derivatives from cat sensorimotor cortex. Life Sci. 1975 Aug 15;17(4):551–555. doi: 10.1016/0024-3205(75)90089-2. [DOI] [PubMed] [Google Scholar]
  18. Sun M. C., McIlwain H., Pull I. The metabolism of adenine derivatives in different parts of the brain of the rat, and their release from hypothalamic preparations on excitation. J Neurobiol. 1976 Mar;7(2):109–122. doi: 10.1002/neu.480070204. [DOI] [PubMed] [Google Scholar]
  19. Sweetman L. Urinary and cerebrospinal fluid oxypurine levels and allopurinol metabolism in the Lesch-Nyhan syndrome. Fed Proc. 1968 Jul-Aug;27(4):1055–1059. [PubMed] [Google Scholar]
  20. Whittaker V. P. Subcellular localization of neurotransmitters. Adv Cytopharmacol. 1971 May;1:319–330. [PubMed] [Google Scholar]
  21. Winn H. R., Rubio R., Berne R. M. Brain adenosine production in the rat during 60 seconds of ischemia. Circ Res. 1979 Oct;45(4):486–492. doi: 10.1161/01.res.45.4.486. [DOI] [PubMed] [Google Scholar]
  22. Winn H. R., Welsh J. E., Rubio R., Berne R. M. Brain adenosine production in rat during sustained alteration in systemic blood pressure. Am J Physiol. 1980 Nov;239(5):H636–H641. doi: 10.1152/ajpheart.1980.239.5.H636. [DOI] [PubMed] [Google Scholar]
  23. Zimmermann H., Denston C. R. Adenosine triphosphate in cholinergic vesicles isolated from the electric organ of Electrophorus electricus. Brain Res. 1976 Jul 30;111(2):365–376. doi: 10.1016/0006-8993(76)90780-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES